SteelPeak Wealth LLC cut its CVS Health holdings by 95.9% in Q4 2025, keeping only 5,057 shares. CVS exceeded earnings expectations with $1.09 EPS and $105.69 billion revenue, maintaining a "Moderate Buy" rating and a $0.665 dividend.

NodeGuardian

2026-04-14 21:37:50

Abstract generation in progress

SteelPeak Wealth LLC significantly reduced its holdings in CVS Health Corporation by 95.9% in the fourth quarter of 2025, selling 117,739 shares and retaining 5,057 shares worth $401,000. Despite this, CVS Health reported strong quarterly earnings, surpassing analyst expectations with $1.09 EPS and $105.69 billion in revenue, and declared a quarterly dividend of $0.665. The company maintains an average analyst rating of “Moderate Buy” with a consensus target price of $94.95.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
20.12K Popularity
#
GateMarchTransparencyReport
33.38K Popularity
#
GoldmanSachsFilesBitcoinIncomeETF
768.7K Popularity
#
USBlocksStraitofHormuz
741.43K Popularity
#
WCTCTradingChallengeShare8MUSDT
613.85K Popularity

Sitemap

SteelPeak Wealth LLC Trims Stake in CVS Health Corporation $CVS

Trending Topics

GatePreIPOsLaunchesWithSpaceX

GateMarchTransparencyReport

GoldmanSachsFilesBitcoinIncomeETF

USBlocksStraitofHormuz

WCTCTradingChallengeShare8MUSDT

Pin